Revvity (RVTY) Hisse Fiyat
Revvity Fiyat
Revvity, son 19 yılda gelirini yıllık %3,3 artırarak 2,86 Md USD seviyesine taşıdı. Hisse başına kâr, son 19 yılda yıllık %4,5 büyüdü. Revvity için net marj, %8,5 ile birkaç yıl önceki %24,6 seviyesine göre geriledi. Bugünkü fiyata göre temettü verimi kabaca %0,19 seviyesine denk geliyor. Temettü dağıtım oranı, kârın yaklaşık %13 düzeyindedir. Revvity için 12 aylık konsensüs fiyat hedefi 140,00 USD; bu, hissenin bugünkü fiyatının yaklaşık %3,6 altında bir seviyeye denk geliyor. 25 analistten 11 tanesi hisse için alım öneriyor — genel konsensüs: Tut.
Revvity hisse senedi fiyatı
Bu verilere Eulerpool API üzerinden ulaşın
Ayda 100.000 ücretsiz istek · kredi kartı yok
Revvity iş modeli ve hisse analizi
Revvity hakkında sık sorulan sorular
PerkinElmer Inc. is a company that focuses on providing products and services in the fields of diagnostics, life sciences, and applied services. Their business model revolves around offering innovative solutions for the healthcare and scientific community. With a wide range of product offerings, including instruments, reagents, consumables, software, and services, PerkinElmer Inc. aims to support scientific research, drug discovery, and diagnostics. By leveraging their expertise in detecting and analyzing biological and environmental challenges, the company strives to enable its customers to improve human and environmental health. PerkinElmer Inc.'s commitment to delivering advanced solutions makes it a trusted partner in the life sciences industry.
PerkinElmer Inc is primarily active in the scientific research and diagnostics industries.
PerkinElmer Inc faces competition from various companies in the market. Some of the main competitors of PerkinElmer Inc include Thermo Fisher Scientific Inc, Agilent Technologies Inc, Waters Corporation, and Bio-Rad Laboratories Inc. These companies also operate in the life science and analytical instrument industries, providing similar products and services. However, PerkinElmer Inc maintains a strong position in the market, leveraging its technological advancements, product innovation, and customer-centric approach to stay competitive in the industry.
PerkinElmer Inc is a highly recognized company in the field of diagnostics, life science research, and applied services. With a rich history dating back to 1937, PerkinElmer Inc has established itself as a global leader in providing innovative solutions to the scientific community. The company's commitment to improving human and environmental health is evident through its extensive range of products, technologies, and services. PerkinElmer Inc actively collaborates with research institutions, pharmaceutical companies, and government agencies to deliver cutting-edge solutions for various scientific challenges. Continuously evolving and expanding, PerkinElmer Inc remains dedicated to driving advancements and enabling breakthrough discoveries in the realms of health, safety, and environmental sustainability.
PerkinElmer Inc has accomplished several significant milestones throughout its history. With over 80 years of experience, the company has become a global leader in providing scientific solutions and technologies. Some notable achievements include the development of innovative diagnostic tools that have revolutionized healthcare, the continuous expansion of its product offering to various industries, and strategic partnerships with leading organizations. PerkinElmer Inc has also received recognition for its commitment to sustainability and social responsibility. These achievements have solidified PerkinElmer Inc's reputation as a trusted provider of high-quality scientific products and services, driving its continuous growth in the market.
PerkinElmer Inc is primarily present in various countries and regions worldwide. As a global leader in life sciences and diagnostics, PerkinElmer has a strong presence in North America, Europe, Asia Pacific, and Latin America. The company operates in over 150 countries, serving customers in academic institutions, government organizations, pharmaceutical companies, and research laboratories. With its expansive reach, PerkinElmer aims to provide innovative solutions and technologies to support advancements in human and environmental health across international borders.
PerkinElmer Inc is a leading global company that specializes in providing innovative solutions for diagnostics, life sciences, and applied services. The company aims to improve the health and well-being of people worldwide through its advanced technologies and scientific expertise. PerkinElmer Inc is committed to delivering reliable and accurate results to its customers, ensuring high-quality products and services. The company's corporate philosophy revolves around promoting sustainability, diversity, and social responsibility. With a strong focus on research and development, PerkinElmer Inc continually strives to drive technological advancements in various industries, making it a trusted leader in its field.
Analistler şu anda Revvity hissesi için ortalama 151,43 USD hedef fiyat belirliyor (medyan: 140,00 USD); bu, son fiyata göre +4,3 % anlamına gelir. Konsensüs 25 analist notuna dayanır.
25 analist şu anda Revvity hissesini değerlendiriyor: 11 al, 14 tut, 0 sat öneriyor. 2026 için analistler Revvity şirketinin 2,87 Md USD gelir ve 5,43 USD hisse başına kâr üretmesini bekliyor.
Güncel döviz kuruyla Revvity hissesi 132,26 EUR (145,22 USD) seviyesindedir.
Revvity hissesi (RVTY) 7 borsada işlem görür, bunlar arasında: NYSE (PKI), London (0KHE.L), SIX (Zürich) (PKN.SW), Frankfurt (PKN.F), München (PKN.MU), Düsseldorf (PKN.DU).
PerkinElmer Inc. is an internationally operating company specializing in the provision of products and services in the fields of life sciences, diagnostics, environmental analysis, and other related markets. The company is headquartered in Waltham, Massachusetts and employs over 13,000 employees worldwide. PerkinElmer offers a wide range of products and services tailored to the needs of its customers. In the field of life sciences, PerkinElmer focuses on researching drug candidates to develop new therapeutics and diagnostic methods. The company offers a variety of instruments, software, and reagents that support laboratory analysis. Diagnostics is another important business area for PerkinElmer. In this area, the company provides products that are tailored to the needs of end consumers. This includes devices for prenatal diagnostics, in-house laboratory diagnostics, and tests in the field of genetic diseases. Another core area of PerkinElmer is environmental analysis. PerkinElmer has a long history in the development and manufacture of instruments and consumables used to identify environmental pollutants and other similar influences. The product range includes chromatography equipment, mass spectrometers, reactive chemicals, and software solutions. PerkinElmer is also active in the field of food analysis. This includes products for the identification of food allergens, analysis of nutritional aspects, and residues of pesticides and other pollutants. Another division involves supporting customers with technical support, such as installation and commissioning of instruments, application questions, and the development of test methods. PerkinElmer also offers research and development services tailored to the needs of its customers. These services include the validation of test methods, testing for the detection of pollutants, and the introduction of automation solutions in the production process. PerkinElmer has expanded its business model to fully meet the needs of its customers. The company builds on its strong expertise and history to offer high-quality products and services. Due to its wide range of products and services, PerkinElmer has expanded into several international markets. The company strives to initiate acquisitions and mergers to continuously expand its business areas. The geographical expansion efforts are primarily focused on Asian countries and other emerging markets. Thanks to its broad product range, targeted services, and international presence, PerkinElmer can make a significant contribution to meeting the requirements and needs of its customers.
beklenen'nin Revvity hasılatı 2,87 Md USD'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.
beklenen'nin Revvity karı 615,06 M USD'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.
Revvity'nin Fiyat/Kazanç (F/K) oranı şu anda 26,73'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Revvity hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.
Revvity'nin Fiyat/Satış (F/S) oranı şu anda 5,74'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Revvity hisse senedinin değerleme metriği olarak hizmet eder.
Revvity'nin Eulerpool Kalite Puanı 0/10'dur.
Revvity'nin ISIN'i US7140461093'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.
Revvity'nin WKN'i 850943'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.
Revvity'nin ticker'ı RVTY'dir. Ticker sembolü, Revvity hisseleri borsada işlem görmek için kullanılır.
Revvity Hissesi
Revvity Emsaller Grubu
Revvity Ticker
Revvity FIGI
Revvity'nin tüm temel göstergeleri ve derinlemesine analizi
Revvity hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Revvity şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: